These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10073647)

  • 1. Bone marrow cells produce soluble factors that inhibit osteoclast activity.
    Ninomiya JT; Bi Y; Banks MA; Lavish SA; Goldberg VM; Greenfield EM
    J Orthop Res; 1999 Jan; 17(1):51-8. PubMed ID: 10073647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
    Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
    Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
    van't Hof RJ; Ralston SH
    J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
    J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption.
    Tan SD; de Vries TJ; Kuijpers-Jagtman AM; Semeins CM; Everts V; Klein-Nulend J
    Bone; 2007 Nov; 41(5):745-51. PubMed ID: 17855178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
    Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W
    Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of RANKL-induced osteoclastic differentiation by vascular cells.
    Tintut Y; Abedin M; Cho J; Choe A; Lim J; Demer LL
    J Mol Cell Cardiol; 2005 Aug; 39(2):389-93. PubMed ID: 15893766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
    Uchiyama S; Yamaguchi M
    Biochem Pharmacol; 2004 Apr; 67(7):1297-305. PubMed ID: 15013845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
    Väänänen K
    Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts.
    Yun JH; Pang EK; Kim CS; Yoo YJ; Cho KS; Chai JK; Kim CK; Choi SH
    J Periodontal Res; 2004 Oct; 39(5):300-7. PubMed ID: 15324350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast-derived activity in the coupling of bone formation to resorption.
    Martin TJ; Sims NA
    Trends Mol Med; 2005 Feb; 11(2):76-81. PubMed ID: 15694870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
    Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
    J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
    Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
    J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoclast culture and resorption assays.
    Bradley EW; Oursler MJ
    Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regucalcin stimulates osteoclast-like cell formation in mouse marrow cultures.
    Yamaguchi M; Uchiyama S
    J Cell Biochem; 2005 Mar; 94(4):794-803. PubMed ID: 15578574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of a cDNA clone encoding a novel peptide (OSF) that enhances osteoclast formation and bone resorption.
    Reddy S; Devlin R; Menaa C; Nishimura R; Choi SJ; Dallas M; Yoneda T; Roodman GD
    J Cell Physiol; 1998 Dec; 177(4):636-45. PubMed ID: 10092216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin.
    Tanaka Y; Abe M; Hiasa M; Oda A; Amou H; Nakano A; Takeuchi K; Kitazoe K; Kido S; Inoue D; Moriyama K; Hashimoto T; Ozaki S; Matsumoto T
    Clin Cancer Res; 2007 Feb; 13(3):816-23. PubMed ID: 17289872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Local factors in bone repair].
    Bergmann P
    Rev Med Brux; 1989 Dec; 10(10):419-23. PubMed ID: 2690263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.